Skip to main content

Table 2 Clinical features and outcomes of our 3 patients with NR1H4-related cholestasis

From: NR1H4 disease: rapidly progressing neonatal intrahepatic cholestasis and early death

ID

Patient 1 (Family I)

Patient 2 (Family II)

Patient 3 (Family III)

Sex

male

male

male

Consanguinity

no

no

no

Family history

no

yes

no

Gestational week

full term

full term

full term

Birth weight (kg)

3.50

4.20

3.85

Age at onset

5.0 days

3.0 days

2.0 days

Age at the first visit

3.0 months

3.0 months

2.5 months

Height

P25th

< P1th

< P1th

Weight

P50th

< P1th

< P1th

Age at last visit

1.6 years

3.0 months

3.0 months

Initial symptom

jaundice

jaundice

jaundice

Hepatic phenotype

low-γ-glutamyl transferase cholestasis, hepatomegaly, and decompensated cirrhosis

low-γ-glutamyl transferase cholestasis and acute liver failure

low-γ-glutamyl transferase cholestasis, acute liver failure, and hepatomegaly

Age at liver biopsy

6.0 months (after liver transplantation)

/

3.0 months

Biopsy findings

swelling of hepatocytes, lymphocytic infiltration, and mild fibrous tissue proliferation

/

hepatocyte ballooning, multi-nucleated giant cells, cholestasis, fibrous tissue proliferation, infiltration of inflammatory cells, bile duct proliferation, hepatocellular necrosis, and decreased BESP expression

Extra-hepatic phenotype

before LT: severe pneumonia, splenomegaly, hydrocele, massive ascites, elevated urinary microalbumin

after LT: EBV infection, bowel obstruction, and right-sided diaphragmatic hernia

severe pneumonia, splenomegaly, and elevated urinary microalbumin

severe pneumonia, cholecystitis, splenomegaly, elevated urinary microalbumin, hyperammonemia, and hydrocele

Liver transplantation (LT)

yes

no

no

Age at LT

4.0 months

/

/

Outcomes

normal liver function at one year’s post-transplant

died of infection at 3 months of age

died of infection at 3 months of age